Bank of New York Mellon Corp Sells 1,279 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Bank of New York Mellon Corp lowered its position in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 1.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 116,896 shares of the company’s stock after selling 1,279 shares during the period. Bank of New York Mellon Corp’s holdings in Addus HomeCare were worth $14,653,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of ADUS. Y Intercept Hong Kong Ltd bought a new position in shares of Addus HomeCare in the 4th quarter worth about $258,000. Handelsbanken Fonder AB grew its holdings in Addus HomeCare by 17.2% in the fourth quarter. Handelsbanken Fonder AB now owns 4,083 shares of the company’s stock worth $512,000 after purchasing an additional 600 shares during the period. Alberta Investment Management Corp purchased a new stake in Addus HomeCare in the fourth quarter worth about $2,116,000. Summit Place Financial Advisors LLC increased its stake in shares of Addus HomeCare by 0.9% during the fourth quarter. Summit Place Financial Advisors LLC now owns 9,410 shares of the company’s stock valued at $1,180,000 after purchasing an additional 80 shares in the last quarter. Finally, TimesSquare Capital Management LLC lifted its holdings in shares of Addus HomeCare by 28.5% during the fourth quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock valued at $44,593,000 after purchasing an additional 78,835 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Down 1.7 %

Shares of NASDAQ ADUS opened at $93.09 on Thursday. The firm’s 50-day moving average price is $117.30 and its 200-day moving average price is $124.04. Addus HomeCare Co. has a 52-week low of $87.88 and a 52-week high of $136.72. The company has a market cap of $1.69 billion, a PE ratio of 21.30, a PEG ratio of 1.41 and a beta of 0.97.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The company had revenue of $297.14 million for the quarter, compared to analysts’ expectations of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. As a group, equities research analysts anticipate that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts recently weighed in on ADUS shares. Oppenheimer upped their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. JMP Securities began coverage on Addus HomeCare in a research note on Monday, December 16th. They issued an “outperform” rating and a $150.00 target price on the stock. Royal Bank of Canada restated an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a report on Thursday, November 14th. StockNews.com cut shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Finally, Macquarie reissued an “outperform” rating and set a $129.00 price objective on shares of Addus HomeCare in a research report on Thursday, February 27th. One research analyst has rated the stock with a sell rating, one has given a hold rating, seven have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $132.78.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the business’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the sale, the chief executive officer now directly owns 79,397 shares in the company, valued at $9,905,569.72. The trade was a 23.95 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 4.60% of the stock is owned by company insiders.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.